RecruitingPhase 3NCT07011745
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Sponsor: Bristol-Myers Squibb
Brooklyn, NY · Staten Island, NY · Valley Stream, NY · +39 more sites